Cargando…
Adapting an immune competent mouse model for glioblastoma T cell therapy
Autores principales: | Rodriguez-Cruz, Tania, Yi, Zhongzhen, Gottschalk, Stephen, Krebs, Simone |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288632/ http://dx.doi.org/10.1186/2051-1426-2-S3-P35 |
Ejemplares similares
-
Genetically Modified T Cells to Target Glioblastoma
por: Krebs, Simone, et al.
Publicado: (2013) -
Targeting the tumor vasculature with TEM8-specific T cells
por: Williams, LaTerrica C, et al.
Publicado: (2014) -
Charachterization and functional analysis of scFv-based CARs to redirect T cells to IL13Rα2-positive glioma
por: Krenciute, Giedre, et al.
Publicado: (2015) -
Combination of a novel oncolytic immunotherapeutic agent, CAVATAK (coxsackievirus A21) and immune-checkpoint blockade significantly reduces tumor growth and improves survival in an immune competent mouse melanoma model
por: Shafren, Darren, et al.
Publicado: (2014) -
P15. A genetic mouse model to identify the role of the immune adapter protein MyD88 in colorectal cancer
por: Holtorf, A, et al.
Publicado: (2014)